Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 1516407 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Ask a Question
Printer Friendly
PDF Brochure
Site LicenseAdd to Basket
EnterprisewideAdd to Basket
Electronic (PDF)Add to Basket
Live Chat Live Help Software for Website

ARQULE - Read-Out Only in 2013

MP Advisors, Sep 2011


  Description  
   Products Mentioned   
    
    
    
     
  Enquire before Buying   
  Send to a Friend   

We remain positive on potential of Tivantinib (formerly ARQ-197, PhIII, c-MET inhibitor, 2nd/3rd-line NSCLC, partnered with Daiichi Sankyo, co-development, worldwide except Asia and Kyowa Hakko Kirin in Asia) but cautious on the B-RAF program, ARQ-736 (PhI, pan-Raf inhibitor, advanced solid tumors) based on our recent interaction with the management.



For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds